The American College of Gastroenterology, Allergan and Ironwood Pharmaceuticals named Kimberly P. of Pennsylvania the “Picture My IBS” winner. The contest encouraged IBS patients to express their irritable bowel syndrome experience through art and narrative.
Immuron Limited received positive news concerning its IMM-124E’s colitis preclinical program at the University of Zurich. IMM-124E showed positive effects on all levels of evaluation, including clinical parameters, tissue level parameters and immunological biomarkers.
Zacks analysts expect Allergan to post earnings of $3.32 per share for the first quarter of fiscal year 2017. Allergan will report its earnings before market open on May 9.
Allergan will present clinical data for Linzess and linaclotide delayed release, Viberzi relamorelin CIV and cenicriviroc, at Digestive Disease Week, May 6 through May 9 in Chicago.
More articles on gastroenterology:
GI leader to know: Dr. Ananya Das of the Arizona Center for Digestive Health
Allergan to present clinical data for new GI treatments: 4 key notes
5 most read GI/endoscopy stories: April 24-April 30, 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.